phosphatidyl serine/stroke

链接已保存到剪贴板

文章临床试验专利权

选择排序类型

5 结果

Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.

只有注册用户可以翻译文章

登陆注册

Anti-phospholipid syndrome (APS) is an autoimmune disease. Cerebral ischemia associated with APS occurs at a younger age than typical atherothrombotic cerebrovascular disease, is often recurrent, and is associated with high positive IgG anti-phospholipid (GPL) unit levels. This study sought to

Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).

只有注册用户可以翻译文章

登陆注册

Children with sickle cell anemia (SCA) have an 11% risk of stroke by the age of 18. Chronic transfusion applied in patients detected to be at risk by transcranial Doppler allows a significant reduction of stroke risk. However, chronic transfusion exposes to several adverse events, including

High frequency of IgM antiphospholipid antibodies in young Iranian patients with stroke.

只有注册用户可以翻译文章

登陆注册

OBJECTIVE To investigate the presence of IgG and IgM types of anticardiolipin (aCL) and antiphospholipid (aPL) antibodies in younger Iranian patients with ischemic stroke. METHODS Both IgG and IgM types of aPL (cardiolipin, anti phosphatidyl inositol, anti phosphatidyl serine, anti phosphatidic acid

Extracellular vesicles in atrial fibrillation and stroke

只有注册用户可以翻译文章

登陆注册

Background: Atrial fibrillation (AF) is associated with a 5-fold increased risk of thromboembolic stroke. Extracellular vesicles (EVs) convey pathophysiological information and are possible biomarkers for risk of stroke.

[Neurological appearances of primary antiphospholipid syndrome].

只有注册用户可以翻译文章

登陆注册

Neurological disturbances frequently emerge in antiphospholipid syndrome (APS). One hundred and twenty four patients (100 women, 24 men, mean age 37.5 +/- 11.3 years) with primary APS (PAPS), including 76 patients with Sneddon's syndrome and positive antibodies to phospholipids (aPL), have been

加入我们的脸书专页

Herbal & Natural Medicine

科学支持的最完整的草药数据库

支持55种语言
科学支持的草药疗法
通过图像识别草药
交互式GPS地图-在位置标记草药（即将推出）
阅读与您的搜索相关的科学出版物
通过药效搜索药草
组织您的兴趣并及时了解新闻研究，临床试验和专利

输入症状或疾病，并阅读可能有用的草药，输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究